Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

71130-06-8

Ranitidine HCl

71130-06-8
87333-19-5

Ramipril

87333-19-5
80214-83-1

Roxithromycin

80214-83-1
23239-51-2

Ritodrine HCl

23239-51-2
7681-76-7

Ronidazole

7681-76-7
112887-68-0

Raltitrexed

112887-68-0
108-46-3

Resorcinol

108-46-3
25875-50-7

Robenidine HCl

25875-50-7
106266-06-2

Risperidone

106266-06-2
1020719-76-9

Risperidone D4

1020719-76-9
73851-70-4

Ranitidin S-oxide

73851-70-4
155213-67-5

Ritonavir

155213-67-5
123441-03-2

Rivastigmine

123441-03-2
287714-41-4

Rosuvastatin

287714-41-4
80621-81-4

Rifaximin

80621-81-4
19395-41-6

Ritalinic acid

19395-41-6
162401-32-3

Roflumilast

162401-32-3
329003-65-8

Risedronate Hemipentahydrate Monosodium

329003-65-8
135062-02-1

Repaglinide

135062-02-1
145202-66-0

Rizatriptan benzoate

145202-66-0